Statistics by Country for Sickle Cell Anemia

Prevalance of Sickle Cell Anemia:

estimated 1 per 1,000 Hispanic Americans are affected by sickle cell disease in the US, Genetics Home Reference website

Prevalance Rate for Sickle Cell Anemia:

approx 1 in 1,000 or 0.10% or 272,000 people in USA [about data]

Extrapolation of Prevalence Rate of Sickle Cell Anemia to Countries and Regions:

WARNING! EXTRAPOLATION ONLY! NOT BASED ON COUNTRY-SPECIFIC DATA SOURCES. The following table attempts to extrapolate the above prevalence rate for Sickle Cell Anemia to the populations of various countries and regions. These prevalence extrapolations for Sickle Cell Anemia are only estimates, based on applying the prevalence rates from the US (or a similar country) to the population of other countries, and therefore may have very limited relevance to the actual prevalence of Sickle Cell Anemia in any region:

Incidence (annual) of Sickle Cell Anemia:

1 per 500 African American births; 1 per 1,000-1,400 Hispanic-American births

Incidence Rate for Sickle Cell Anemia: approx 1 in 34,000 or 0.00% or 8,000 people in USA [about data] Extrapolation of Incidence Rate for Sickle Cell Anemia to Countries and Regions: WARNING! EXTRAPOLATION ONLY. NOT BASED ON COUNTRY-SPECIFIC DATA SOURCES. The following table attempts to extrapolate the above incidence rate for Sickle Cell Anemia to the populations of various countries and regions. As discussed above, these incidence extrapolations for Sickle Cell Anemia are only estimates and may have very limited relevance to the actual incidence of Sickle Cell Anemia in any region:

About extrapolations of prevalence and incidence statistics for Sickle Cell Anemia:

WARNING! EXTRAPOLATED STATISTICS ONLY! Not based on data sources from individual countries. These statistics are calculated extrapolations of various prevalence or incidence rates against the populations of a particular country or region. The statistics used for prevalence/incidence of Sickle Cell Anemia are typically based on US, UK, Canadian or Australian prevalence or incidence statistics, which are then extrapolated using only the population of the other country. This extrapolation calculation is automated and does not take into account any genetic, cultural, environmental, social, racial or other differences across the various countries and regions for which the extrapolated Sickle Cell Anemia statistics below refer to. The extrapolation does not use data sources or statistics about any country other than its population. As such, these extrapolations may be highly inaccurate (especially for developing or third-world countries) and only give a general indication (or even a meaningless indication) as to the actual prevalence or incidence of Sickle Cell Anemia in that region. These statistics are presented only in the hope that they may be interesting to some people.

About prevalence and incidence statistics in general for Sickle Cell Anemia:

The word 'prevalence' of Sickle Cell Anemia usually means the estimated population of people who are managing Sickle Cell Anemia at any given time (i.e. people with Sickle Cell Anemia). The term 'incidence' of Sickle Cell Anemia means the annual diagnosis rate, or the number of new cases of Sickle Cell Anemia diagnosed each year (i.e. getting Sickle Cell Anemia). Hence, these two statistics types can differ: a short disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.